Press release
Keratoconus Pipeline Assessment Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Curious about the latest updates in the Keratoconus Pipeline? Click here to explore the therapies and trials making headlines @ Keratoconus Pipeline Outlook Report [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Keratoconus Pipeline Report
* In July 2025, Price Vision Group announced a study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.
* DelveInsight's Keratoconus Pipeline report depicts a robust space with 3+ active players working to develop 3+ pipeline therapies for Keratoconus treatment.
* The leading Keratoconus Companies such as Epion Therapeutics Inc., iVeena Delivery Systems and others.
* Promising Keratoconus Therapies such as Riboflavin 5'-Phosphate, IVMED-80, Riboflavin, Dextenza, Prednisolone Acetate and others.
Want to know which companies are leading innovation in Keratoconus? Dive into the full pipeline insights @ Keratoconus Clinical Trials Assessment [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
The Keratoconus Pipeline Report provides disease overview, pipeline scenario and therapeutic assessment of the key pipeline therapies in this domain. The Keratoconus Pipeline Report also highlights the unmet needs with respect to the Keratoconus.
Keratoconus Overview
Keratoconus is an eye (ocular) disorder characterized by progressive thinning and changes in the shape of the cornea. The cornea is the thin, clear outer layer of the eye and is normally dome-shaped. Slowly progressive thinning of the cornea causes a cone-shaped bulge to develop towards the center of the cornea in the areas of greatest thinning. Affected individuals develop blurry or distorted vision, sensitivity to light (photophobia), and additional vision problems. Keratoconus often begins at puberty and most often is seen in teenagers or young adults. The specific underlying cause is not fully understood and most likely the condition results from the interaction of multiple factors including genetic and environmental ones.
Keratoconus Emerging Drugs Profile
* EpiSmart: Epion Therapeutics, Inc.
Epion has developed a drug, drug delivery device that fully optimize cross-linking and allow for the minimally-invasive treatment for corneal ectasias, including keratoconus. Unlike current treatments for keratoconus, EpiSmart is designed to be implemented upon initial diagnosis and can prevent disease progression. Epion's elegant approach elevates the current standard of care for keratoconus by enabling the treatment of both eyes simultaneously and eliminating the need for further deterioration. EpiSmart is an investigational drug-device combination product. EpiSmart and its components (Epiprep, Ribostat, and UVA Device) are not yet approved by the Food and Drug administration or by other regulatory bodies. Currently, the drug is in Phase III stage of its development for the treatment of Keratoconus.
* IVMED-80: iVeena Delivery Systems
IVMED-80 is a proprietary non-surgical, non-invasive, disease modifying intervention with FDA orphan designation that upregulates lysyl oxidase (LOX) and induces corneal crosslinking pharmacologically. Upon issuance, the patent will provide US protection until at least 2041. The patent will protect key compositions and formulations of IVMED-80. In November 2020, the drug candidate received a $1.68 M in Federal government grants for its keratoconus developmental program. Currently the drug is in Phase II stage of development for the treatment of Keratoconus.
If you're tracking ongoing Keratoconus Clinical trials, this press release is a must-read. Tap to see the breakthroughs @ Keratoconus Treatment Drugs [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
The Keratoconus Pipeline report provides insights into:-
* The report provides detailed insights about companies that are developing therapies for the treatment of Keratoconus with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Keratoconus Treatment.
* Keratoconus Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Keratoconus Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Keratoconus market.
Keratoconus Companies
Epion Therapeutics Inc., iVeena Delivery Systems and others.
Keratoconus Pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as,
* Oral
* Parenteral
* Intravitreal
* Subretinal
* Topical.
Keratoconus Products have been categorized under various Molecule types such as,
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
From emerging drug candidates to competitive intelligence, the Keratoconus Pipeline Report covers it all - check it out now @ Keratoconus Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Keratoconus Pipeline Report
* Coverage- Global
* Keratoconus Companies- Epion Therapeutics Inc., iVeena Delivery Systems and others.
* Keratoconus Therapies- Riboflavin 5'-Phosphate, IVMED-80, Riboflavin, Dextenza, Prednisolone Acetate and others.
* Keratoconus Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Keratoconus Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Stay ahead in Healthcare Research - discover what's next for the Keratoconus Treatment landscape in this detailed analysis @ Keratoconus Emerging Drugs and Major Players [https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Keratoconus: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Keratoconus - DelveInsight's Analytical Perspective
* In-depth Commercial Assessment
* Keratoconus Collaboration Deals
* Late Stage Products (Phase III)
* EpiSmart: Epion Therapeutics, Inc.
* Mid Stage Products (Phase II)
* IVMED-80: iVeena Delivery Systems
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug Name- Company name
* Drug profiles in the detailed report.....
* Pre-clinical and Discovery Stage Products
* Drug Name- Company name
* Drug profiles in the detailed report.....
* Inactive Products
* Keratoconus Key Companies
* Keratoconus Key Products
* Keratoconus- Unmet Needs
* Keratoconus- Market Drivers and Barriers
* Keratoconus- Future Perspectives and Conclusion
* Keratoconus Analyst Views
* Keratoconus Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=keratoconus-pipeline-assessment-report-2025-emerging-therapies-clinical-developments-and-drug-insights-by-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/keratoconus-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Keratoconus Pipeline Assessment Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight here
News-ID: 4218801 • Views: …
More Releases from ABNewswire
UK Composer Jools Scott Releases Free Choir Sheet Music for SATB and Children's …
British composer Jools Scott releases five original compositions as free choir sheet music PDF downloads - two SATB pieces and three children's choir works with piano accompaniment. No sign-up required.
BRISTOL, England - Feb. 23, 2026 - British composer Jools Scott today released five original compositions as free choir sheet music for directors, music educators and singers. The collection spans SATB and children's choir voicings, with each piece available as a…
Colorado Springs Residents Are Turning to This Tint Company for Fast, Profession …
Turbo Tint Colorado Springs offers fast, warranty-backed window tinting, PPF, and ceramic coating at 5680 East Woodmen Road. Locally owned by Bert and Valerie Bennett, the shop delivers one-hour installs and a 5-star experience.
The demand for professional window tinting services in Colorado Springs has grown steadily as vehicle owners look for ways to protect their cars from intense UV exposure and high-altitude sun damage. Among the businesses meeting that demand,…
Manaslu Circuit Trek Emerges as Nepal's Leading Wilderness Adventure for 2026
Kathmandu, Nepal - February 23, 2026 - As global trekkers shift toward quieter and less commercialized Himalayan routes, the Manaslu Circuit Trek has emerged as one of Nepal's fastest-growing high-altitude adventures for 2026. Industry sources in Kathmandu confirm a noticeable rise in early bookings from Europe, North America, and Australia.
The trek circles Mount Manaslu, which stands at 8,163 meters and ranks as the world's eighth highest mountain. The route crosses…
Charlotte Homeowners Urged to Prioritize Dryer Vent Cleaning Amid Rising Fire Sa …
The Better Home Pros in Charlotte highlights the fire risks posed by neglected dryer vents and offers expert preventive maintenance across 26 communities in NC and SC.
The National Fire Protection Association has reported that clothes dryers account for thousands of home fires each year across the United States. A significant number of these incidents stem from clogged or poorly maintained vents, making routine maintenance a non-negotiable part of responsible homeownership.…
More Releases for Keratoconus
Valley Optometry Eyecare Center Brings Advanced Keratoconus Treatment to Reseda …
Image: https://www.globalnewslines.com/uploads/2025/09/1758898268.jpg
Valley Optometry Eyecare Center stands as a cornerstone of comprehensive eye care throughout the Greater Los Angeles region. The practice has earned recognition for combining traditional optometric wisdom with modern diagnostic capabilities. Patients from across the San Fernando Valley have come to depend on this facility for everything from basic vision screenings to complex medical interventions that preserve sight.
Keratoconus presents unique challenges that can leave patients feeling hopeless about…
Valley Optometry Eyecare Broadens Awareness Around Reseda Keratoconus Treatment …
Image: https://www.globalnewslines.com/uploads/2025/08/1754401929.jpg
Valley Optometry Eyecare remains a steady presence in the Los Angeles eye care landscape, recognised for its careful, technology-driven approach to diagnosis and long-term treatment. Operating at the intersection of clinical precision and patient accessibility, the centre continues to address lesser-known but increasingly prevalent conditions affecting local vision health.
Among these concerns, keratoconus stands out for its complexity and the subtlety of its onset. Affecting the shape and strength of…
Valley Optometry Eyecare Provides Breakthrough Keratoconus Therapy
Image: https://www.globalnewslines.com/uploads/2025/05/1748342525.jpg
Valley Optometry Eyecare stands at the forefront of advanced eye care for Southern California residents. The practice operates from its central location with modern equipment and highly trained staff ready to tackle complex vision problems. Eye health specialists at this established center work tirelessly to address conditions many patients fear might permanently affect their sight. Valley Optometry Eyecare has earned trust within the community through consistent results and attention…
Keratoconus Treatment Market Size, Share, Trends, Growth and Competitive Analysi …
"Keratoconus Treatment Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. A detailed market research study of this report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as…
Keratoconus Market Size, Share, Trends And Forecast To 2034
How big is the keratoconus market?
The keratoconus market reached a value of US$ 202.1 Million in 2023 and expected to reach US$ 275.0 Million by 2034, exhibiting a growth rate (CAGR) of 2.84% during 2024-2034.
The report offers a comprehensive analysis of the keratoconus market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in…
Keratoconus Market Size, Growth, Research Report & Trends 2023-2033
Keratoconus Market Report Overview:
Report Attribute Details
Base Year …
